Reason: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Distributed: U.S. Nationwide Including Puerto RicoReason: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Distributed: U.S. Nationwide Including Puerto RicoReason: Lack of Assurance of Sterility; improperly crimped fliptop vials
Distributed: NationwideReason: Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.
Distributed: NationwideReason: Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.
Distributed: Pfizer shipped the affected product to 4,447 direct accounts. No federal government accounts received the affected product directly from Pfizer Inc.Reason: Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.
Distributed: AZReason: Defective Container: Vials may be missing stoppers.
Distributed: Nationwide and Puerto RicoReason: Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.
Distributed: US Nationwide including Puerto RicoReason: Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated for the 18 month stability time point for ketone cilexetil impurity and total impurities.
Distributed: NationwideReason: Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.
Distributed: Nationwide, Puerto Rico, and U.S. Virgin Islands.